[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.232.62.209. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 26, 1941

VITAMIN E AND VITAMIN B6: CLINICAL EXPERIENCE IN THE TREATMENT OF MUSCULAR DYSTROPHY AND AMYOTROPHIC LATERAL SCLEROSIS

Author Affiliations

NEW YORK
From the Departments of Medicine and Neurology, Columbia University College of Physicians and Surgeons, and the Presbyterian Hospital and Neurological Institute.

JAMA. 1941;116(17):1895-1896. doi:10.1001/jama.1941.02820170013005
Abstract

Recent experiments on animals1 have suggested the possibility that muscular dystrophy and amyotrophic lateral sclerosis might be deficiency diseases. In some clinics therapeutic trials with vitamin E preparations and vitamin B6 (pyridoxine hydrochloride) appear to have justified this conclusion.2 Because the problem of the etiology and treatment of these disorders is one of considerable importance and because it is complicated by the absence of a clear demonstration that a deficiency of either vitamin E or vitamin B6 exists in these conditions, we are presenting our observations, which have failed to indicate that added amounts of these vitamins are of benefit to patients with muscular dystrophy or amyotrophic lateral sclerosis. Similar results as far as vitamin E (synthetic tocopherol) is concerned have recently been reported by Shelden, Butt and Woltman.3

MATERIAL  With two exceptions the subjects of this study were patients at either the Neurological Institute

×